An institute without walls to further collaborations in translational medicine for pediatric cancer
Beth Anne Baber,
Co-Founder, CEO, and President
The Nicholas Conor Institute for Pediatric Cancer Research
|
|
Abstract: The Nicholas Conor Institute is a non-profit medical research organization that supports transition of pediatric cancer diagnostics and therapies from research bench to the clinic. The Institute employs an innovative model of mutually beneficial partnerships within the biomedical community to promote development of personalized treatment plans for children with cancer.
Our Mission is to meet pediatric cancer head on with better detection and diagnostic tools as well as kid friendly treatments that bring hope to all those involved:
· By translating biomedical discoveries into integrated, personalized treatment programs
· By developing cancer-specific predictive tests to guide cancer therapy for each child
· By bringing to the clinic new therapies that consider the unique molecular physiology of each child children and his or her cancer.
The Nicholas Conor Institute will identify and further develop promising discoveries and technologies from academia that would greatly impact the treatment of cancer in children. These potentially life saving discoveries would otherwise languish due to the small market that children with cancer occupy.
As a translational medical research organization, The Nicholas Conor Institute has adopted a hub-and-spoke distribution model where the nodes are essentially incubator labs within our industry partners’ domain. We are neither virtual nor a stand alone institute. Instead, The Nicholas Conor Institute is an academic institute without walls.
Presenter Biography: Beth Anne has more than 20 years of academic experience in molecular biology, neurobiology and physiology, cell biology, developmental biology, cancer biology, and signal transduction. Her current research focuses on the understanding of the molecular mechanisms involved in DNA damage repair following treatment with radiation and chemotherapeutic agents. Her work in DNA damage signaling has led to publications in major scientific journals, including Nature and Science. The National Institute of Health, the Leukemia and Lymphoma Society and the Beckman Laser Institute funded her research initiatives at the Salk Institute. Beth Anne received her PhD in Macromolecular Cellular Structure and Chemistry from The Scripps Research Institute. She is the 2007 DLA Piper-Athena FlexMBA Scholarship recipient and received her MBA from the University of California-San Diego Rady School of Management in August 2009. Beth Anne is the mother of Nicholas Conor Boddy, a pediatric cancer survivor.
|
